Stanley-Laman Group, Ltd. - TARO PHARMACEUTICAL INDS LTD ownership

TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 165 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2016. The put-call ratio across all filers is 1.03 and the average weighting 0.3%.

Quarter-by-quarter ownership
Stanley-Laman Group, Ltd. ownership history of TARO PHARMACEUTICAL INDS LTD
ValueSharesWeighting
Q1 2016$519,000
-84.3%
3,625
-83.1%
0.10%
-82.7%
Q4 2015$3,315,000
+10.1%
21,447
+1.7%
0.57%
-7.3%
Q3 2015$3,012,000
-9.6%
21,080
-9.1%
0.61%
+0.5%
Q2 2015$3,331,00023,1800.61%
Other shareholders
TARO PHARMACEUTICAL INDS LTD shareholders Q1 2016
NameSharesValueWeighting ↓
Claret Asset Management Corp 86,474$6,524,0001.34%
Analyst IMS Investment Management Services Ltd. 28,438$2,143,0000.64%
ALGERT GLOBAL LLC 20,876$1,575,0000.59%
Quantinno Capital Management LP 9,351$706,0000.48%
Crestline Management, LP 37,000$2,792,0000.45%
Empirical Finance, LLC 9,561$721,0000.20%
BRANDES INVESTMENT PARTNERS, LP 55,065$5,469,0000.14%
FORT, L.P. 9,672$730,0000.14%
CAXTON ASSOCIATES LP 8,865$669,0000.13%
ACADIAN ASSET MANAGEMENT LLC 330,448$24,928,0000.11%
View complete list of TARO PHARMACEUTICAL INDS LTD shareholders